Lifecore Biomedical, Inc. \de\

Lifecore Biomedical, Inc. \de\

LFCR· Manufacturing· Fiscal year ends in May

CEO pay in FY2025Stock +15.9% in FY2025

Paul Josephs is the CEO of Lifecore Biomedical, Inc. \de\ and was paid $1.1M in FY2025 (May), down 89%.

Pay$100 in the stock at the end of FY23 → $83
CEO pay is from each Lifecore Biomedical, Inc. \de\ proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives4

See all
  1. 1Ryan D. LakeFY2025
  2. 2Thomas D. SalusFY2025
  3. 3Paul JosephsFY2025
  4. 4John D. MorbergFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Lifecore Biomedical, Inc. \de\ paid its 4 named executives $10.3M in total in FY2025 (May). CEO Paul Josephs was paid $1.1M of that.

Name
Ryan D. LakeExecutive Vice President, Chief Financial OfficerNot disclosedNot disclosed
Thomas D. SalusChief Legal and Administrative OfficerNot disclosedNot disclosed
Paul JosephsPresident and Chief Executive OfficerNot disclosed
John D. MorbergFormer Executive Vice President, Chief Financial Officer

of each named executive, from the Summary Compensation Table of each proxy.

Peers22

See all

The FY2025 (May) proxy of Lifecore Biomedical, Inc. \de\ names 22 peer companies for pay. Among Lifecore Biomedical, Inc. \de\ and these peers, CEO pay was the lowest of 7 and total shareholder return was 4th highest of 7.

7th highest of 7in Lifecore Biomedical, Inc. \de\ and its pay peers, FY2025 (May) by CEO pay:

$1.1M$6.9M

4th highest of 7in Lifecore Biomedical, Inc. \de\ and its pay peers, FY2025 (May) by total shareholder return:

$19$402

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board1

See all
  • Jason AryehDirector · 1 yr on the boardIndependentAudit, Nominating and Corporate Governance—Paid as an executive

The board of the latest proxy (FY2025).

Shared directors

Activity

  1. Pay
    Lifecore Biomedical, Inc. \de\ CEO pay fell 89% to $1.1M. The stock rose 20% in FY2025 (May).
    DEF 14A
  2. Pay
    Lifecore Biomedical, Inc. \de\ Former CFO pay fell 42% to $756.2K. The stock rose 20% in FY2025 (May).
    DEF 14A
  3. Pay
    Lifecore Biomedical, Inc. \de\ Former CFO pay rose 40% to $1.3M. The stock fell 29% in FY2024 (May).
    DEF 14A
  4. Pay
    Lifecore Biomedical, Inc. \de\ Former CFO pay rose 50% to $927.1K. The stock fell 20% in FY2023 (May).
    DEF 14A
  5. Pay
    Lifecore Biomedical, Inc. \de\ Former CFO pay fell 10% to $618.0K. The stock fell 21% in FY2022 (May).
    DEF 14A
  6. Pay
    Lifecore Biomedical, Inc. \de\ CEO pay rose 93% to $1.8M. The stock fell 20% in FY2023 (May).
    DEF 14A
  7. Pay
    Lifecore Biomedical, Inc. \de\ President pay rose 40% to $1.3M. The stock fell 20% in FY2023 (May).
    DEF 14A
  8. Pay
    Lifecore Biomedical, Inc. \de\ President pay fell 15% to $956.8K. The stock fell 21% in FY2022 (May).
    DEF 14A

Filings5

See all
Proxy statementDEF 14ASep 18, 2025FY2025
Annual report10-KAug 7, 2025FY2025
Annual report10-KAug 26, 2024FY2024
Proxy statementDEF 14AJul 19, 2024FY2023
Annual report10-KMar 20, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data